SMITH ASSET MANAGEMENT GROUP LP - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2014$29,000
+3.6%
1,4040.0%0.00%0.0%
Q4 2013$28,000
-56.2%
1,4040.0%0.00%
-66.7%
Q3 2013$64,000
+93.9%
1,4040.0%0.00%
+200.0%
Q2 2013$33,0001,4040.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 762,941$7,248,0007.29%
NEXTHERA CAPITAL LP 711,558$6,760,0002.79%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 585,930$4,366,0002.71%
Consonance Capital Management LP 1,155,793$10,980,0000.81%
Pier Capital, LLC 423,667$4,025,0000.80%
KNOTT DAVID M 155,795$1,480,0000.70%
Eventide Asset Management 1,086,400$10,321,0000.46%
Empire Life Investments Inc. 373,863$3,552,0000.32%
Telemetry Investments, L.L.C. 41,588$395,0000.25%
Polar Capital LLP 2,302,666$21,875,0000.23%
View complete list of STEMLINE THERAPEUTICS INC shareholders